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Abstract of thesis presented to the Senate of Universiti Putra Malaysia in 
fulfilment of the requirements for the degree of Master of Science. 
THE EFFECT OF N-NITROSODIMETHYLAMINE ON ENZYME 
ACTIVITIES AND HISTOLOGY IN THE MOUSE. 
By 
MOHD. NAZIL SALLEH 
July 1999 
Chairman: Associate Professor Johari Ramli, Ph.D. 
Faculty : Science and Environmental Studies 
This thesis studied the effects of acute, sub-chronic and chronic exposures of 
NDMA on the enzyme activities of five tumour markers namely: glutathione S-
transferase (GST), gamma glutamyl transpeptidase (y-GT), glutathione peroxidase 
(GSH-Px), glutathione reductase (GSH-R) and uridyl diphosphoglucuronyl 
transferase (UDPGT) in the liver and kidney of male mice were. Forty-eight male 
mice ICR strain, Mus musculus (26-3 8g, 8 weeks old) were divided into four 
groups. A single batch consisted of 12 mice; one-half of them for enzyme 
activities and the other one-half for histological study. Acute group (n= 1 2) were 
injected with a single dose of 0 . 5  mg/kg b.w. of NDMA. Sub-chronic group 
received 0.25 mg/kg b.w. of NDMA with twice i.p. injection over a one month 
xii 
period. Chronic group (n= 1 2) were injected with 0 .05 mg/kg b.w. of NDMA given 
four times over a period of four month. The mice were sacrificed by cervical 
dislocation after treatment. In the liver, acute, sub-chronic and chronic exposure to 
NDMA showed increased enzyme activities (GST, GSH-R, GSH-Px, y-GT and 
UDPGT: except y-GT at acute exposure) in comparison with control groups 
(P<0.05). In the kidney, however the effect of NDMA exposure was rather 
inconsistent. All the enzyme activities increased in the acute exposure. Meanwhile, 
in the sub-chronic and chronic exposure some enzyme activities increased (e.g.: 
GST, y-GT and UDPGT) and some enzyme activities (e.g.: GSH-R) did not 
change significantly. Administration of NDMA to mice by intraperitoneal 
injection over various periods of times to a total of 0.05- 0 .5  mg/kg body weight 
caused the development of the tumour in the liver and kidney. Single acute dose 
(0.5 mg/kg b.w. of NDMA) produced anaplastic tumour and tubular degeneration 
in the kidney. Prolonged exposure (chronic) of mice to NDMA produced a high 
incidence of hepatocellular adenoma and also necrosis in the liver. This study 
demonstrated that there is a very strong correlation between enzyme activities and 
cell damage. Therefore, it can be concluded that some enzyme activities especially 
GST, y-GT and UDPGT can be used as tumour markers. 
xiii 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains. 
KESAN N-NITRODIMETILAMINA (NDMA) KE ATAS AKTIVITI 
ENZIM DAN HISTOLOGI PADA MENCIT. 
Oleh 
MOHD. NAZIL SALLEH 
Julai 1999 
Pengerusi : Profesor Madya Johari Ramli, Ph.D. 
Fakulti : Sains dan Pengajian Alam Sekitar 
Hasil daripada kesan akut, sub-kronik dan kronik akibat daripada 
pendedahan NDMA ke atas aktiviti enzim penanda tumor; glutation S-transferase 
(GST), gama-glutamiltransferase (y-GT), glutation peroksidase (GSH-Px), glutation 
reduktase (GSH-R) dan uridil difosfoglukuronil transferase (UDPGT) di dalam 
hati dan ginjal mencit. Empat puluh lapan (n=48) mencit jantan Mus musculus ICR 
strain (26-38g berat badan; berusia 7-8 minggu) telah dibahagikan kepada 4 
kumpulan. Dalam satu kumpulan mengandungi 12 ekor mencit ; 6 ekor untuk 
aktiviti enzim dan 6 ekor lagi bagi tujuan histologi. Kumpulan akut (n=1 2) mencit 
menerima sekali suntikan di bahagian kaviti peritonial pada kadar dos 0 .5  mg/kg 
NDMA mengikut berat badan. Bagi kumpulan sub-kronik mencit menerima dua 
kali suntikan sepanjang tempoh 4 minggu dengan kadar dos 0 .25 mg/kg NDMA 
xiv 
mengikut berat badan. Manakala kumpulan kronik menerima empat kali suntikan 
sepanjang tempoh 1 6  minggu dengan kadar dos 0 .05 mg/kg NDMA mengikut 
berat badan. Kesemua mencit dibunuh secara dislokasi servikal selepas tempoh 
kajian. Kesemua aktiviti enzim didapati meningkat (GST, GSH-R, GSH-Px, y-GT 
and UDPGT; kecuali y-GT pada akut) pada hati mencit apabila di bandingkan 
dengan kumpulan kawalan (p<0 .05). Manakala pada ginjal mencit kesan 
pendedahan NDMA adalah tidak stabil . Kesemua aktiviti enzim meningkat pada 
tempoh akut. Pada tempoh sub-kronik dan kronik kebanyakan aktiviti enzim 
meningkat (contoh: GST, y-GT dan UDPGT) dan ada juga aktiviti enzim tidak 
menunjukan signifikans (contoh: GSH-R). Penyuntikan NDMA ke atas mencit 
pada pelbagai tempoh masa dengan jumlah akhir 0 .05 - 0 .5 mg/kg berat badan 
menyebabkan pertumbuhan tumor ke atas hepar dan ginjal. Penyuntikkan kadar 
dos yang tinggi (0.5  mg/kg berat badan) pada tempoh akut menghasilkan anaplasia 
tumor dan inflamasi tubul pada ginjal. Pemanjangan tempoh pendedahan (kronik) 
Pada mencit memberi kesan yang tinggi ke atas pembentukan nekrosis dan 
ademomas tumor pada hati. Kajian ini menunjukkan terdapat ikatan yang kuat di 
antara aktiviti enzim dan kerosakan sel . Oleh yang demikian ianya boleh 
disimpulkan; sebahagian aktiviti enzim mampu menjadi penunjuk kehadiran tumor 
yang baik (GST, y-GT dan UDPGT) 
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CHAPTER I 
INTRODUCTION 
Mankind have been plagued by diseases throughout the history of 
civilisation. Through advances in medical science, most of these diseases have 
been overcome. In the twentieth century, cancer has become one of the most 
important killer diseases in the world. Only in this century, the population has 
become acutely aware of its significance. Being one of the major human health 
problems, it has received enormous biomedical attention over the past few 
decades. Approximately a hundred types of human cancer have been recognised. 
Cancer is the second leading cause of death after heart disease. From 
epidemiological studies, about 35% of cancer are related to diet (Hodgson & Levi, 
1 994). 
Cancer can be characterised as the loss of normal growth regulation. As 
we know, when normal stability of the organisation of tissues and organs are 
disturbed, a variety of diseases will arise. It is also characterised as groups of cells 
that arise from a single cell (Pitot et al . ,  1 989). It is general knowledge that the 
body is developed from a single cell formed by the union of the male sperm and 
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the female egg. This cell divides into two and these two divides again. Divisions 
of their progeny continue generation after generation and the cell formed undergo 
progressive alterations to fit them for the various roles they are destined to play. 
Cells, even when they are fully grown, continue to divide, replacing worn out 
tissues, repairing injuries and healing wounds. 
Cancer cells are different from normal cells. They divide excessively to 
form lumps or tumour. The excessive growth of cells is due to the failure of cell 
proliferation control (disturbance of the control mechanism). Normal cells stop 
growing when they touch each other, a phenomenon known as contact inhibition. 
Cancer cells however are under no such control and therefore form lumps of cells 
called nodules. In other words cancer is the' outlaw cell '  . 
It is well documented that cancer development in organs and tissues is induced by 
different types of carcinogenic stimuli, including chemicals, viruses and radiation 
(Scott , 1 979) . The first indication that exposure to chemical agents might cause 
cancer was when Percival Pott ( 1 775) noted that chimneysweepers, exposed to 
soot, were liable to scrotum cancer (IARC, 1 99 1 ) .  Chemicals have been shown to 
exhibit carcinogenic activity in experimental animals .  
In the modern industrialised world, cancer has become the most feared of 
all diseases. It  is a progressively fatal disease for which no treatment has yet been 
discovered. 
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Studies on cancer have been carried out, histologically (Kessler et aI. ,  
1 992), histochemically (Ogawa et  aI . ,  1 980) and cytologically (Cameron et aI . ,  
1 988).  However, very few studies have been done on the correlation between 
biochemical assay and histological effects. The carcinogenic process in the mice 
liver and kidney was evaluated by the determination of the marker enzymes; 
glutathione S-transferase, glutathione reductase, glutathione peroxidase, y­
glutamyl transpeptidase and uridine diphosphate glucuronyl transferase. 
Marker enzyme activities are expected to show a rise because of the 
change in the enzyme synthesis rate, principally to the increase in the number of 
cells synthesising the enzymes. During carcinogenesis, cancer cells undergo 
abnormal cell growth and the number of cells increase very rapidly. These 
enzymes can be used as marker enzymes and diagnostic tool for cancer (Moss, 
1 987). 
Lesion sconng IS very important III order to determine the severity of 
tumours (Mostofi & Dans, 1 998). The microscopic changes in the liver and kidney 
tumours are studied to create the lesions scoring for liver and kidney tumours. The 
pathologic and inflammatory changes in the liver and kidney tumours are different 
among the same species of animals or humans (Henry et aI. ,  1 997). Hence, the 
microscopic lesions scoring system outlined in this study was developed to 
evaluate and classify the severity of liver and kidney lesion. 
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The aim of this study is to investigate the effect of chemical carcinogen (N-
nitrosodimethylamine) on tumour marker enzyme activities by chemical 
carcinogenesis (N-nitrosodimethylamine) in the liver and kidney of male mice, 
mainly to : 
I) Determine enzyme activities of GST, GSH-Px, GSH-R, y-GT and 
UDPGT in the liver and kidney. 
II) Study of liver and kidney histology after treatment with NDMA 
III) Study the correlation between cell damage and enzyme activities 
IV) Histological study and lesion Scoring 
CHAPTER II 
LITERA TURE REVIEW 
Chemical Carcinogenesis 
Approximately 80-90% of cancer incidence in human beings is caused by 
environmental factors. These environmental factors include diet, chemicals, 
biological agents and ionising radiation. Chemical carcinogenesis is a process that 
consists of many steps with exposure to complex compounds in the environment. 
Carcinogenic agents, which enter the body, compete with the active metabolism 
pathway and detoxification. Most of the exogenous chemicals will be metabolised 
and excreted through various specific steps, which is also involved in the 
formation of reactive mediating agent. This reactive species will interact 
covalently with macromolecules within the cell and has the potential to start 
carcinogenesis and mutagenesis (Philips et aI. ,  1 985) .  Most industrial chemicals in 
our environment cause cancer. Carcinogenic substance was shown to be involved 
in the formation of free radicals (T' sao & Caspary, 1 977). 
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Carcinogenesis is caused through the production of free radicals .  Free 
radicals are produced through oxidising metabolism, mainly through peroxidation 
of polyunsaturated fatty acids (Carpenter, 1 99 1 )  and it is also a reactive species of 
oxygen, as well as play an important role in the promotion of tumour (Sharma et 
al., 1 994) . These free radicals activate the proto-oncogen. Free radicals which are 
produced in the oxidation process attack cells, cellular proteins, enzymes, lipid 
membranes and DNA strands. When the carcinogen activates the proto-oncogen, it 
will increase the production of proteins to abnormal levels. 
Chemical Carcinogen 
Polycyclic aromatics, aromatic amine, aflatoxin and N-nitrosamines have 
been identified as carcinogens (Weston & Harris, 1 99 1 ) . Chemical carcinogens 
can be divided into two major categories: genotoxic agents which produce 
alterations in the genetic material of the host and epigenetic agents which do not 
alter the primary sequence of DNA. The genotoxic agents possess cancer initiating 
activity whereas the epigenetic compounds possess cancer promoting activity 
(Hodgson & Levi, 1 994) . 
A chemical carcinogen only becomes active after being metabolised to the 
'ultimate ' carcinogen form (the neoplasia-initiating derivative) but there are 
exceptions for alkylating agents. The 'ultimate' carcinogen form also has a strong 
electrophilic reaction. The 'ultimate' carcinogen consists of electron starved 
atoms and can react with nucleophilic site which can be found in abundance in 
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DNA, RNA and protein, including some oxygen and nitrogen atoms in protein 
(Miller, 1 978). The chemical interaction of carcinogen with DNA causes the 
symptoms of cancer or a genetic i llness. This i l lness will be transferred down 
from the parent cell to the progeny in every cell cycle. This is linked to the change 
in the nucleotide in DNA and the change in the gene transcription (Miller & 
Miller, 1 98 1 ) . 
Mechanism of Carcinogenesis 
Carcinogenesis is a multistage process driven by carcmogen induced 
genetic and epigenetic damage in susceptible cell that gains a selective growth 
activation of proto-oncogens or inactivation of tumour suppressor genes (Harris, 
1 99 1 ). 
The development of a single cell into malignant tumour occurs in three 
stages as shown in Figure 1 : -
Initiation 
The first stage of carcinogenic process is tumour initiation (Tappe!, 1 988) .  
It involves exposure of normal cells to chemical, genetic, physical or microbial 
carcinogens that cause genetic changes providing the initiated cells with both an 
altered responsiveness to their micro environment and exerts a selective clonal 
expansion advantage when compared to the surrounding normal cells (Yuspa & 
Harris, 1 982). The initiated cells may have a decreased response to the intra- and 
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Figure 1 : A Model of the Process of Multistage Carcinogenesis showing the Three Stage 
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inter-cellular signals that maintain normal tissue texture and regulate the 
homeostatic growth and maturation of cells (Weinstein et al. , 1 984). Initiated cells 
are also less responsive to negative growth factors. 
Initiating agents are chemical, physical or biological agents, which are 
capable of directly altering the molecular structure of the genetic component 
(DNA) of the cell. The alteration may be a result of a covalent reaction of DNA 
with the initiating agents itself or with one of its metabolites. For example, during 
the administration of hepatocarcinogens (initiating agents) to an organism, several 
focal and nodular hyperplastic lesions develop in the liver cells. These focal and 
nodular hyperplasias are likely candidates for precursors of hepatic carcinoma. 
Hyperplastic nodules have two biological options after the 'initiation' process. 
The first option is to regress where a majority of the hyperplastic nodules will 
disappear in a process variously termed as regression (Farber, 1 963) or 
'remodelling' or 'phenotypic maturation' into normal structure of liver. The 
second option is, the hyperplastic nodules persist and undergo the second stage of 
neoplasm development. 
Promotion 
Tumour promotion results in the proliferation or survival of the initiated 
cells to a greater extent than normal cells and enhance the probability of additional 
genetic damage including endogenous mutations and accumulation in the 
expanding population of the cells (Weston & Harris, 1 99 1 ) .  The probability of  a 
